Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis | Haematologica
Antibodies gone bad – the molecular mechanism of light chain amyloidosis - Absmeier - The FEBS Journal - Wiley Online Library
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis | NEJM
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? | JACC: Cardiovascular Imaging
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy - ScienceDirect
AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy - ScienceDirect
Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis | PLOS ONE
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases - Garcia‐Pavia - 2021 - European Journal of Heart Failure -
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment - Gertz - 2020 - American Journal of Hematology - Wiley Online Library
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
What do I need to know about immunoglobulin light chain (AL) amyloidosis? - ScienceDirect
Hemato | Free Full-Text | Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics | Nature Communications
Biochemical and genetic evaluation in amyloidosis - ppt video online download
Hemato | Free Full-Text | Mechanisms of Organ Damage and Novel Treatment Targets in AL Amyloidosis
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Frontiers | Understanding AL amyloidosis with a little help from in vivo models
Immunoglobulin-Related Amyloidosis: Practice Essentials, Pathophysiology, Etiology
free light chains ratio in AL amyloidosis, kappa and lambdaAmyloidosis Patient Information Site
Journal of Lancaster General Health - Journal of Lancaster General Hospital
